Want to join the conversation?
Specialty chemical solutions provider and American Fortune 500 company $ASH said that it has entered into a uncollared accelerated share repurchase (ASR) agreement with Goldman Sachs & Co. to repurchase an aggregate of $500MM of $ASH common stock. In April 2015, $ASH's BoD approved a $1Bil share repurchase authorization expiring December 2017.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.